Similarly, in the authors’ previous study evaluating results one month after the fourth treatment, both the acne filter and the 590-nm filter demonstrated good therapeutic efficacy for MGD with no significant differences in clinical parameters, including TBUT, MMP-9 expression, MG parameters, and OSDI scores [18]. The gene discussed is MMP9; the disease is myasthenia gravis.